The trademark application DIGITAL DRUG ASSIGNMENT was filed by GENOMATE HEALTH INC., a U.S. corporation (the "Applicant"). Application under examination.
The application was filed in English (Italian was selected as the second language).
The Refusal with reference B 019057053 was Rejected according to Article 7(1)(b) EUTMR with decision issued on April 23, 2025 by the EUIPO.
Goods And Services
The mark was filed in class 42 with following description of goods:
Biological research
Medical research
Scientific research
Research services in the field of genomic science
Technology advisory services related to genomic research
Scientific research in the field of genomics
Software as a service (SAAS) services featuring software used for the analysis of genomes, molecular diagnostic tests to predict treatment response and improve diagnostics in the medical, scientific and biological fields
Interactive web-based communication platform as a service for medical and biological data sharing, namely, disease, treatment, trial, outcome and molecular diagnostic test results for decision support
Science and technology services.
The mark was filed in class 44 with following description of goods:
Health counseling
Medical clinic services
Medical services
Pharmaceutical advice
Telemedicine services
Health care services, namely, personalized therapy services and clinical decision support services
Consulting services in the field of health care to assist with biomedical and clinical decisions
Medical diagnostic testing, monitoring and reporting services in personalized medicine.